News
Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...
Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.
Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...
Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...
Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.
Paris is known for many things, from romance to art to world-beating croissants. But perhaps one of its lesser-known attributes is that it is a thriving hub for biotech and life sciences.In fact, the ...
Having just enough of a fatty substance (lipid) called cholesterol in your body is important for bodily functions, but having too much of it, known as high cholesterol, can increase your risk of ...
Immunotherapies in high demand; fueling R&D. The immunotherapy market size was valued at $226.38 billion last year, and it is only projected to grow by almost 12% by 2030, according to Grand View ...
Top biotech M&As of May 2025. In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced ...
London is one of the U.K.’s major biotech hubs and is considered to be part of the “Golden Triangle” – essentially a cluster of biotech excellence – alongside Oxford and Cambridge.The capital city is ...
Cure51 began testing NVIDIA’s Parabricks toolkit on H100 GPUs and DGX Cloud infrastructure as a way to accelerate its workflows. According to internal benchmarking data, the company saw up to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results